Track topics on Twitter Track topics that are important to you
HealthLinx is an emerging theranostics company and is formerly Cryptome Pharmaceuticals. Cryptome's acquisition of HealthLinx Pty. Ltd. has secured world-wide exclusive licenses for biomarkers that have application within the predictive diagnostic market-space, in particular for the diagnosis of cances and adds to its therapeutics focus.
The company completed the merger on 14th February 2006 and officially changed the name of the company on 16th March 2006.
HealthLinx is developing novel, non-invasive, serum-based, diagnostic products and a platform for generating therapeutic and nutraceutical peptide leads. Currently proceeding with, the company is Phase II biomarker trials for two diagnostic products and has significant IP in Protein Deletion Technologies with the first product being developed as a disposable spin colum that depletes serum of up to 98% of protiens. The company also has some early preclinical therapeutic peptides in development stage and is supported by a strong development pipeline targeting, disease states with un-met market needs.
HealthLinx seeks to enter strategic partnerships using its Cryptomics, Biomarker Discovery and Protein Depletion Platforms .
Level 5, Suite 3,55 Swanston Street,
Phone: 61 3 9639 6349
Fax: 61 3 9639 7855
JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...
Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...
Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
HealthLinx is an emerging theranostics company and is formerly Cryptome Pharmaceuticals. Cryptome's acquisition of HealthLinx Pty. Ltd. has secured world-wide exclusive licenses for biomarkers that ha...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...
We have published hundreds of HealthLinx Limited news stories on BioPortfolio along with dozens of HealthLinx Limited Clinical Trials and PubMed Articles about HealthLinx Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HealthLinx Limited Companies in our database. You can also find out about relevant HealthLinx Limited Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...